These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Molecular modeling information transfer with VRML: from small molecules to large systems in bioscience. Moeckel G; Keil M; Exner T; Brickmann J Pac Symp Biocomput; 1998; ():327-38. PubMed ID: 9697193 [TBL] [Abstract][Full Text] [Related]
7. Structures of cytochrome P450 3A4. Scott EE; Halpert JR Trends Biochem Sci; 2005 Jan; 30(1):5-7. PubMed ID: 15653318 [TBL] [Abstract][Full Text] [Related]
8. Human P450s involved in drug metabolism and the use of structural modelling for understanding substrate selectivity and binding affinity. Lewis DF; Ito Y Xenobiotica; 2009 Aug; 39(8):625-35. PubMed ID: 19514836 [TBL] [Abstract][Full Text] [Related]
9. Probing ligand binding modes of human cytochrome P450 2J2 by homology modeling, molecular dynamics simulation, and flexible molecular docking. Li W; Tang Y; Liu H; Cheng J; Zhu W; Jiang H Proteins; 2008 May; 71(2):938-49. PubMed ID: 18004755 [TBL] [Abstract][Full Text] [Related]
10. Computational solvent mapping reveals the importance of local conformational changes for broad substrate specificity in mammalian cytochromes P450. Clodfelter KH; Waxman DJ; Vajda S Biochemistry; 2006 Aug; 45(31):9393-407. PubMed ID: 16878974 [TBL] [Abstract][Full Text] [Related]
11. Using molecular modeling and molecular dynamics simulation to predict P450 oxidation products. Paulsen MD; Manchester JI; Ornstein RL Methods Enzymol; 1996; 272():347-57. PubMed ID: 8791794 [No Abstract] [Full Text] [Related]
12. Designing better drugs: predicting cytochrome P450 metabolism. de Groot MJ Drug Discov Today; 2006 Jul; 11(13-14):601-6. PubMed ID: 16793528 [TBL] [Abstract][Full Text] [Related]
14. Photochromic agents as tools for protein structure study: lapachenole is a photoaffinity ligand of cytochrome P450 3A4. Gartner CA; Wen B; Wan J; Becker RS; Jones G; Gygi SP; Nelson SD Biochemistry; 2005 Feb; 44(6):1846-55. PubMed ID: 15697210 [TBL] [Abstract][Full Text] [Related]
15. Computational approaches for predicting CYP-related metabolism properties in the screening of new drugs. Crivori P; Poggesi I Eur J Med Chem; 2006 Jul; 41(7):795-808. PubMed ID: 16644065 [TBL] [Abstract][Full Text] [Related]
16. Compound lipophilicity for substrate binding to human P450s in drug metabolism. Lewis DF; Jacobs MN; Dickins M Drug Discov Today; 2004 Jun; 9(12):530-7. PubMed ID: 15183161 [TBL] [Abstract][Full Text] [Related]
17. Structural determinants of cytochrome P450 substrate specificity, binding affinity and catalytic rate. Lewis DF; Eddershaw PJ; Dickins M; Tarbit MH; Goldfarb PS Chem Biol Interact; 1998 Oct; 115(3):175-99. PubMed ID: 9851289 [TBL] [Abstract][Full Text] [Related]
18. Ligand Access Channels in Cytochrome P450 Enzymes: A Review. Urban P; Lautier T; Pompon D; Truan G Int J Mol Sci; 2018 May; 19(6):. PubMed ID: 29848998 [TBL] [Abstract][Full Text] [Related]
19. Homology modelling of Drosophila cytochrome P450 enzymes associated with insecticide resistance. Jones RT; Bakker SE; Stone D; Shuttleworth SN; Boundy S; McCart C; Daborn PJ; ffrench-Constant RH; van den Elsen JM Pest Manag Sci; 2010 Oct; 66(10):1106-15. PubMed ID: 20583201 [TBL] [Abstract][Full Text] [Related]
20. Modelling human cytochrome P450-substrate interactions. Lewis DF Ernst Schering Res Found Workshop; 2002; (37):235-48. PubMed ID: 11975198 [No Abstract] [Full Text] [Related] [Next] [New Search]